m+Medelevator.RU
← Поиск публикаций
Regenerative therapy · 2026

Stimuli-responsive 4D-bioprinted constructs for musculoskeletal tissue regeneration: Shape-morphing mechanisms, cell-laden bioink engineering, and preclinical outcomes.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mohammad Suleiman Ibrahim, Vasudevan Asokan, Chohan Jasgurpreet Singh, Salman Ahmed Fekry, Singh Manveet, Singh Ripendeep, Bains Pardeep Singh, Abdulkhakimov Parvoz, Astaneh Mohammad Ebrahim, Fereydouni Narges

Аннотация

INTRODUCTION: Musculoskeletal disorders impose a substantial global disability burden. Conventional 3D bioprinting cannot replicate the dynamic, anisotropic architecture of bone, cartilage, skeletal muscle, and cardiac muscle. Four-dimensional (4D) bioprinting addresses this by integrating stimuli-responsive materials into constructs, enabling programmed shape transformation and adaptive behavior following implantation.

METHODS: This narrative review examines primary experimental research on stimuli-responsive 4D-bioprinted musculoskeletal constructs, drawing on in vitro, in vivo, and combined outcomes from leading peer-reviewed journals.

RESULTS: Evidence spans four stimuli modalities - magnetic actuation, near-infrared (NIR) photothermal response, thermoresponsive swelling-shrinking transitions, and shape memory polymer (SMP) recovery - applied across bone, cartilage, skeletal muscle, and cardiac constructs. Bioink formulations from silk fibroin-gelatin composites and alginate-polydopamine inks to GelMA-based hydrogels and polyester SMPs present trade-offs between printability, shape fidelity, and cellular compatibility. Cross-study synthesis identifies stiffness trajectory, architectural anisotropy, and dynamic deformation as primary mechano-biological axes directing cell fate decisions. Preclinical studies document encouraging ossification and chondrogenesis outcomes, though constructs fall short of native tissue mechanical benchmarks.

CONCLUSION: Translational barriers range from fundamental physical constraints - including the mechanical performance gap and stimulus penetration depth limitations - to incremental engineering challenges amenable to near-term resolution. Passive hydration-driven deployment represents the most clinically tractable strategy, while multifunctional bioinks integrating stimuli-responsiveness, bioactive factor presentation, and cell-instructive surface chemistry define the primary material development direction.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты